AR081769A1 - Derivados indazolicos e intermediarios para su produccion, utiles como agentes profilacticos o terapeuticos para enfermedades degenerativas coriorretinales - Google Patents
Derivados indazolicos e intermediarios para su produccion, utiles como agentes profilacticos o terapeuticos para enfermedades degenerativas coriorretinalesInfo
- Publication number
- AR081769A1 AR081769A1 ARP110101839A ARP110101839A AR081769A1 AR 081769 A1 AR081769 A1 AR 081769A1 AR P110101839 A ARP110101839 A AR P110101839A AR P110101839 A ARP110101839 A AR P110101839A AR 081769 A1 AR081769 A1 AR 081769A1
- Authority
- AR
- Argentina
- Prior art keywords
- production
- useful
- chorioretinal
- formula
- compound represented
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cardiology (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuesto representado por la fórmula (1) o una sal farmacéuticamente aceptable del mismo que tiene un efecto supresor sobre la muerte de las células fotorreceptoras en un modelo en ratón de trastorno por la luz. Por lo tanto, es útil como agente profiláctico o terapéutico para una enfermedad degenerativa coriorretinal sustancialmente no acompañada de neovascularización, por ejemplo, degeneración macular de tipo seco relacionada con la edad, retinitis pigmentosa, atrofia girata de coroides y retina, y para un trastorno coriorretinal que acompaña a una enfermedad con dichas características. También se provee un compuesto representado por la fórmula (1) o una sal del mismo y un intermediario para su producción para utilizar en la profilaxis o terapia de la enfermedad degenerativa coriorretinal, y el uso de un compuesto representado por la fórmula (1) o una sal del mismo farmacéuticamente aceptable para la producción de un agente profiláctico o terapéutico para la enfermedad degenerativa coriorretinal.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010121821 | 2010-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR081769A1 true AR081769A1 (es) | 2012-10-17 |
Family
ID=45003996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110101839A AR081769A1 (es) | 2010-05-27 | 2011-05-27 | Derivados indazolicos e intermediarios para su produccion, utiles como agentes profilacticos o terapeuticos para enfermedades degenerativas coriorretinales |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP2012006919A (es) |
| AR (1) | AR081769A1 (es) |
| TW (1) | TW201202214A (es) |
| WO (1) | WO2011149010A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2656292T3 (es) * | 2012-05-01 | 2018-02-26 | Translatum Medicus Inc. | Métodos de tratamiento y diagnóstico de enfermedades oculares que causan ceguera |
| AU2014285301A1 (en) * | 2013-07-04 | 2016-01-21 | Nippon Soda Co., Ltd. | Phenylimidazole derivative, and therapeutic medicine or preventive medicine for inflammatory disease, etc. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002083175A1 (fr) * | 2001-04-11 | 2002-10-24 | Senju Pharmaceutical Co., Ltd. | Agents ameliorant la fonction visuelle |
| KR101163800B1 (ko) * | 2003-10-15 | 2012-07-09 | 산텐 세이야꾸 가부시키가이샤 | 신규 인다졸 유도체 |
| WO2006112313A1 (ja) * | 2005-04-13 | 2006-10-26 | Ube Industries, Ltd. | インダゾール誘導体を有効成分として含む網膜神経細胞保護剤 |
-
2011
- 2011-05-25 TW TW100118267A patent/TW201202214A/zh unknown
- 2011-05-26 JP JP2011118031A patent/JP2012006919A/ja not_active Withdrawn
- 2011-05-26 WO PCT/JP2011/062070 patent/WO2011149010A1/ja active Application Filing
- 2011-05-27 AR ARP110101839A patent/AR081769A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201202214A (en) | 2012-01-16 |
| JP2012006919A (ja) | 2012-01-12 |
| WO2011149010A1 (ja) | 2011-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20160087A7 (es) | Indazolcarboxamidas, procedimientos para su preparación, preparaciones farmacéuticas que las contienen | |
| DOP2019000187A (es) | Compuestos de 5-metil-1,2,4-oxadiazol-3-ilo | |
| ECSP20013248A (es) | Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos | |
| DOP2019000168A (es) | Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer | |
| PH12015501942A1 (en) | Susbtituted 3-phenylpropylamine derivatives for the treatment of opthalmic diseases and disorders | |
| BR112017007662A2 (pt) | composto, composição farmacêutica, processo de elaboração de uma composição farmacêutica, método de tratamento de distúrbio ou doença relativa a er, kit de tratamento e uso de composto | |
| BR112015029512A8 (pt) | derivados de pirazolopirrolidina, seus usos, e composição e combinação farmacêuticas | |
| CO2017000399A2 (es) | Inhibidores de cinasa de interacción con proteína cinasa activada por mitógeno (mnk) y métodos relacionados con los mismos | |
| CR20160205A (es) | Inhibidores de kras g12c | |
| CO6741217A2 (es) | Modulares de receptor de glucagón | |
| UY36465A (es) | Compuestos policíclicos de carbamoilpiridona y su uso farmacéutico | |
| ECSP11011067A (es) | Compuestos para el tratamiento de enfermedades y desórdenes oftalmológicos | |
| ECSP13012611A (es) | Derivados de pirazol-aminopirimidina como moduladores de la lrrk2 | |
| UY36207A (es) | Inhibidores de la syk | |
| AR090241A1 (es) | INHIBIDORES DE LA b-SECRETASA | |
| CO2020016582A2 (es) | Sales de sepiapterina farmacéuticamente aceptables | |
| CO2021005532A2 (es) | Derivados de quinolina como inhibidores de la integrina alfa4beta7 | |
| ECSP11010956A (es) | Compuestos enlazados con azufre para el tratamiento de enfermedades y trastornos oftalmicos | |
| MX2020003732A (es) | Derivado de anillo fusionado como inhibidor del receptor a2a. | |
| EA201691656A2 (ru) | Терапевтические способы с применением норибогаина и родственных соединений | |
| AR062395A1 (es) | Uso de derivados del 2.5-dihidroxibenceno para el tratamiento de enfermedades oculares | |
| UY37729A (es) | NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7 | |
| BR112019004236A2 (pt) | compostos para tratar doenças associadas a uma disfunção mitocondrial | |
| CO2019010029A2 (es) | Compuestos de tipo imidazo[4,5-c]quinolin-2-ona deuterados y su uso en el tratamiento del cáncer | |
| BR112016026552A8 (pt) | derivados de carboxamida, seus usos, composição farmacêutica, e combinação |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |